A pregnancy is considered ''prolonged'' from 41 weeks of gestation. Prolonged Pregnancies (PP) are associated with increased maternal morbidity: emergency caesarean, 3rd and 4th degree perineal lesions and postpartum haemorrhage. Foetuses are at increased risk of oligohydramnios, meconium-staining and Fetal Heart Rate (FHR) anomalies. Around 15% of all pregnancies are prolonged. A Cochrane review on induction of labour showed that a policy of labour induction at or beyond 41 weeks was associated with significantly fewer perinatal deaths. Thus the French College of Obstetricians and Gynaecologists stated, "induction of labour can be proposed to patients between 41+0 and 41+6 weeks of gestation". In cases where labour is induced and cervix is unfavourable, cervical ripening is advised. Methods of cervical ripening include pharmacological (prostaglandins) and mechanical (Foley catheter or trans-cervical double balloon) methods. Those two methods were compared in the PROBAAT trial among women with term pregnancies (beyond 37+0). The rates of caesarean section with these two strategies were identical, however uterine hyper stimulation with FHR anomalies occurred less when cervical ripening was mechanical. Considering pharmacological cervical ripening is associated with more uterine hyper stimulation and more FHR anomalies, it may not be the most appropriate in cases of fragile foetuses that include cases of prolonged pregnancies. Considering prolonged pregnancies are associated with a risk of FHR anomalies and that cervical ripening with a pharmacological method is another factor which increases this risk: women with prolonged pregnancies could benefit from a more "gentle" cervical ripening. At present, no particular method is recommended in cases of cervical ripening and prolonged pregnancies. We hypothesise that, in cases of prolonged pregnancies, mechanical cervical ripening, with less uterine hyperstimulation and fewer FHR anomalies, could be more appropriate and could reduce the rate of caesarean section for suspicion of fetal distress.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
1,224
The mechanical cervical ripening is a double transcervical balloon. The device used in the study is the Cook® Cervical Ripening Balloon with CE marked (commercialized by the Cook® laboratory, ref JCRBS-184000). It is a silicone double balloon catheter. Maximum balloon inflation is 80 mL/balloon. It will be used in accordance with user manual
The comparative pharmacological procedure is a vaginal slow releasing system of dinoprostone. The form used in the study is Propess (Ferring pharmaceuticals) containing 10mg of dinoprostone (prostaglandin E2). It will be used in accordance with Summary of Product Characteristics
Chu Brest
Brest, France
CHU CAEN
Caen, France
Ch Pontoise
Cergy-Pontoise, France
Ch Chartres
Chartres, France
Chu Clermont-Ferrand
Clermont-Ferrand, France
Ch Departemental Vendee
La Roche-sur-Yon, France
Hopital Saint Joseph
Marseille, France
Chu Nantes
Nantes, France
Chi Poissy
Poissy, France
Chu Reims
Reims, France
...and 4 more locations
Caesarean section rate for non-reassuring fetal status.
Indication of the caesarean section will be settled by an adjudication committee at the end of the study
Time frame: Up to 2 days after cervical ripening
Time between cervical ripening and delivery in hours
Evaluation of time between cervical ripening and delivery in hours
Time frame: Up to 2 days after cervical ripening
Delivery rate after 12 and 24 hours of cervical ripening
Evaluation of delivery rate after 12 and 24 hours of cervical ripening
Time frame: up to 2 days after cervical ripening
Induction with oxytocin
yes/no
Time frame: up to 2 days after cervical ripening
Total dose of oxytocin required for induction of labour
evaluation of total dose of oxytocin required for induction of labour
Time frame: up to 2 days after cervical ripening
Uterine hyper stimulation defined as more than 6 contractions by 10 minutes over a 30 minutes period
uterine hyperstimulation
Time frame: up to 2 days after cervical ripening
Requirement for tocolysis during cervical ripening or during labour
requirement for tocolysis
Time frame: up to 2 days after cervical ripening
Suspicious or pathological fetal heart rate
FIGO classification
Time frame: up to 2 days after cervical ripening
Uterine rupture
yes/no
Time frame: up to 2 days after cervical ripening
Use of analgesics during labour
yes/no
Time frame: up to 2 days after cervical ripening
Use of antibiotics during labour
yes/no
Time frame: up to 2 days after cervical ripening
Indication for caesarean delivery other than non-reassuring FHR
(failure to progress in first or second stage of labour or maternal indication)
Time frame: up to 2 days after cervical ripening
Type of vaginal delivery
spontaneous or instrumental, indication for instrumental delivery
Time frame: up to 2 days after cervical ripening
Maternal intra partum infection
Suspicion of maternal intra partum infection
Time frame: up to 2 days after cervical ripening
Maternal post partum infection
Suspicion of post partum infection
Time frame: up to 2 days after cervical ripening
Maternal post partum haemorrhage
Post partum haemorrhage defined as estimated blood loss \> 500 cc
Time frame: up to 2 days after cervical ripening
Maternal blood transfusion
Blood transfusion
Time frame: up to 2 days after cervical ripening
Neonatal apgar score
Apgar score at 1, 3, 5 and 10 minutes
Time frame: at 1, 3, 5 and 10 minutes after delivery
Neonatal arterial ph
Arterial pH at delivery
Time frame: at delivery
Intensive care unit for newborn
Admission in an intensive care unit
Time frame: up to 5 days after cervical ripening
Neonatal respiratory insufficiency
Respiratory insufficiency with necessity of any respiratory support
Time frame: up to 5 days after cervical ripening
Birth asphyxia
Birth asphyxia defined as pH\<7, Base Excess \>12 mmol/l and encephalopathy.
Time frame: up to 5 days after cervical ripening
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.